| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29f435299b17bbfcd0d79e42219752d4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26 |
| filingDate |
1998-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45ac74eb651b9e55559d0f5d1aa4d427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3faa99616f82d452988a2f68186a480
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9eb7c5cd6b7bc03075484f6bbbf7e1a9 |
| publicationDate |
1998-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H10287633-A |
| titleOfInvention |
Cyclopropylglycine compounds for the treatment of central nervous system disorders |
| abstract |
(57) [Problem] To provide a cyclopropylglycine compound for treating a central nervous system disease. SOLUTION: A compound having the following formula or a pharmaceutically acceptable salt thereof is used. Embedded image Wherein R 1 is C 1-6 alkyl and R 2 is H or 9-xanthylmethyl. |
| priorityDate |
1997-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |